Understanding how older sexual and gender minorities in Nigeria decide to engage in anal cancer prevention.
Official title: Engaging Leaders to Elicit Viewpoints on Anal Cancer Prevention (ELDERS) study
Funded at University of Maryland Baltimore · NIH-11020415 · Data updated 2026-11-12
This study is looking to understand how older LGBTQ+ individuals living with HIV in Nigeria feel about joining programs that help prevent anal cancer, so we can make these programs more appealing and accessible for them.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | September 15, 2022 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $100,000 |
| NIH project number | 3U01CA275053-03S1 |
| Project ID | NIH-11020415 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older sexual and gender minorities living with HIV in Nigeria, particularly those aged 45 and older.
✕Less likely to help
Patients who do not identify as sexual or gender minorities or those who are not living with HIV may not benefit from this research.
What this research studies
This research focuses on older sexual and gender minorities (SGM) living with HIV in Nigeria, who are at a significantly higher risk for anal cancer. The study aims to gather insights from this demographic to understand their preferences and viewpoints regarding participation in anal cancer prevention programs. By identifying barriers such as privacy concerns and socioeconomic factors, the research seeks to tailor prevention strategies that resonate with older SGM. The ultimate goal is to enhance engagement in cancer screening among this high-risk group.
Why it matters
Potential benefit: If successful, this research could lead to improved anal cancer prevention strategies that effectively engage older sexual and gender minorities, potentially reducing their risk of developing advanced anal cancer.
How similar studies have gone: While this approach is tailored to a specific demographic, similar studies have shown success in engaging high-risk populations in cancer prevention through culturally sensitive strategies.
Where this research is happening
-
University of Maryland Baltimore
Baltimore, United States Active
Researchers
- Principal investigator: Nowak, Rebecca G. — University of Maryland Baltimore
- Study coordinator: Nowak, Rebecca G.
Related research
Other NIH-funded projects on the same topics.
-
Integrated approach to preventing anal cancer in HIV+ MSM through screening and treatment of HSIL
This project tests a streamlined plan to prevent anal cancer in people living with HIV by screening for HSIL and treating it at clinics serving MSM.
-
Preventing anal cancer in people living with HIV
A topical form of HIV protease inhibitors is being tried to clear precancerous anal changes in people living with HIV.
-
Screening strategies to find anal cancer precursors in high-risk people
Researchers will study markers from DNA methylation and immune signals to better identify people at risk for anal cancer before it develops.
-
Integrated approach to preventing anal cancer in HIV-positive MSM through HSIL screening and treatment
This project tests a proven HSIL screening-and-treatment approach to prevent anal cancer in men living with HIV, using Ghana/Nigeria-based sites to learn how to implement it broadly.
-
Better screening for anal cancer in people at higher risk
This project looks for biological and immune signals that could spot early precancerous changes in people at high risk for anal cancer.
-
Screen-and-treat program to prevent anal cancer in people with HIV
This project offers regular anal screening and treatment to men who have sex with men living with HIV to lower their risk of anal cancer.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.